US: 1.646.568.9797 (24x5)
UK: 44.330.808.0580 (24x5)
Worldwide: 91.703.051.960 (24x7)
AbstractThe report covers the forecast and analysis of the brain tumor diagnosis and treatment market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes the drivers and restraints for the brain tumor diagnosis and treatment market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the brain tumor diagnosis and treatment market on a global level. In order to give the users of this report a comprehensive view of the brain tumor diagnosis and treatment market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness. The report provides company market share analysis in order to give a broader overview of the key market players. In addition, the report also covers the key strategic developments of the market including acquisitions and mergers, new service diagnosis type launch, agreements, partnerships, collaborations, and joint ventures, research and development, service diagnosis type, and regional expansion of major participants involved in the market. The study provides a decisive view on the brain tumor diagnosis and treatment market by segmenting it on the product, diagnosis type, treatment type, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further categorization into major countries including the U.S., UK, Germany, France, China, Japan, India, Brazil, etc. This segmentation includes the demand for brain tumor diagnosis and treatment market based on all the segments in all the regions and countries. The key players in the global brain tumor diagnosis and treatment market are GE Healthcare, AstraZeneca, Carestream Health, Pfizer, Inc., Merck & Co. Inc., Siemens Healthineers, Hitachi Medical Corporation, Philips Healthcare, Toshiba Medical Systems Corporation, and Shimadzu Corporation. This report segments the global brain tumor diagnosis and treatment market as follows: Global Brain Tumor Diagnosis and Treatment Market: Product Segment Analysis Primary Brain Tumor Meningioma Gliomas Astrocytomas Pituitary Tumors Other Primary Brain Tumors Secondary Brain Tumor Global Brain Tumor Diagnosis and Treatment Market: Diagnosis Type Segment Analysis CT Scan MRI PET-CT Scan Molecular Testing EEG Others Global Brain Tumor Diagnosis and Treatment Market: Treatment Type Segment Analysis Surgery Radiation Therapy Targeted Therapy Chemotherapy Immunotherapy Global Brain Tumor Diagnosis and Treatment Market: Regional Segment Analysis North America U.S. Europe UK France Germany Asia Pacific China Japan India Latin America Brazil Middle East and Africa
Table of Contents Request Table Of Content Click To Request Sample Chapter 1. Introduction 1.1. Report description and scope 1.2. Research scope 1.3. Research methodology 1.3.1. Market research process 1.3.2. Market research methodology Chapter 2. Executive Summary 2.1. Global brain tumor diagnosis and treatment market, 2015 - 2024 (USD Million) 2.2. Global brain tumor diagnosis and treatment ma | read more...